ClinicalTrials.govpublic full text
AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy
head and neck squamous cell carcinoma, low-dose radiotherapy, low-dose radiation, cadonilimab, ctla-4, pd-1, stereotactic body radiation therapy, hybrid radiation, immune modulation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877852
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.